|
Demographic and tumour characteristics
|
IHC defined breast cancer subtypes
|
P value
|
|---|
|
Luminal A
|
Luminal B
|
HER2 enriched
|
TNBC
|
|---|
|
n
|
%
|
n
|
%
|
n
|
%
|
n
|
%
|
|---|
|
Age in years
|
≤50
|
131
|
37.1%
|
35
|
9.9%
|
53
|
15.0%
|
134
|
38.0%
|
0.015
|
|
>50
|
65
|
32.3%
|
35
|
17.4%
|
40
|
19.9%
|
61
|
30.3%
|
|
Nationality
|
Sudanese
|
153
|
35.0%
|
56
|
12.8%
|
73
|
16.7%
|
155
|
35.5%
|
0.924
|
|
Eritrean
|
42
|
36.2%
|
14
|
12.1%
|
20
|
17.2%
|
40
|
34.5%
|
|
Histologic type
|
aIDCNST
|
159
|
33.3%
|
65
|
13.6%
|
85
|
17.8%
|
168
|
35.2%
|
0.056
|
|
bILC
|
16
|
61.5%
|
1
|
3.8%
|
5
|
19.2%
|
4
|
15.4%
|
|
Medullary
|
0
|
0.0%
|
0
|
0.0%
|
0
|
0.0%
|
13
|
100.0%
|
|
Mucinous
|
16
|
94.1%
|
1
|
5.9%
|
0
|
0.0%
|
0
|
0.0%
|
|
Papillary
|
1
|
6.7%
|
3
|
20.0%
|
2
|
13.3%
|
9
|
60.0%
|
|
Cribriform
|
4
|
100.0%
|
0
|
0.0%
|
0
|
0.0%
|
0
|
0.0%
|
|
Pathologic tumour size
|
pT1
|
45
|
47.9%
|
14
|
14.9%
|
10
|
10.6%
|
25
|
26.6%
|
.041
|
|
pT2
|
74
|
31.1%
|
35
|
14.7%
|
48
|
20.2%
|
81
|
34.0%
|
|
pT3
|
43
|
31.2%
|
13
|
9.4%
|
23
|
16.7%
|
59
|
42.8%
|
|
pT4
|
27
|
40.3%
|
7
|
10.4%
|
9
|
13.4%
|
24
|
35.8%
|
|
Lymph Node involvement
|
pN0
|
102
|
42.7%
|
31
|
13.0%
|
34
|
14.2%
|
72
|
30.1%
|
0.58
|
|
pN1
|
22
|
27.5%
|
10
|
12.5%
|
19
|
23.8%
|
29
|
36.3%
|
|
pN2
|
25
|
29.8%
|
15
|
17.9%
|
14
|
16.7%
|
30
|
35.7%
|
|
pN3
|
12
|
21.4%
|
8
|
14.3%
|
7
|
12.5%
|
29
|
51.8%
|
|
Nottingham Grade
|
GI
|
19
|
67.9%
|
3
|
10.7%
|
4
|
14.3%
|
2
|
7.1%
|
0.000
|
|
GII
|
123
|
45.7%
|
25
|
9.3%
|
36
|
13.4%
|
85
|
31.6%
|
|
GIII
|
54
|
21.0%
|
42
|
16.3%
|
53
|
20.6%
|
108
|
42.0%
|
-
a
IDCNST= invasive ductal carcinoma, no special type, b
ILC= invasive lobular carcinoma
